Ticker Scorecard - SUPN Basics Company: Supernus Pharmaceuticals, Inc. IPO Date: May 1, 2012 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $1.82B Activated in VL: True Average Daily Range Avg Daily Range: $0.47 | 2.03% Avg Daily Range (30 D): $0.53 | 1.42% Avg Daily Range (90 D): $0.55 | 1.50% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): .33M Avg Daily Volume (90 D): .28M Trade Size Avg Trade Size (Sh.): 94 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 47 Institutional Trades Total Inst.Trades: 4,073 Avg Inst. Trade: $1.61M Avg Inst. Trade (30 D): $1.85M Avg Inst. Trade (90 D): $1.96M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.88M Avg Closing Trade (30 D): $2.5M Avg Closing Trade (90 D): $2.51M Avg Closing Volume: 61.45K     News Feb 11, 2025 @ 9:30 PM Supernus Pharmaceuticals to Host Conference Call a... Source: N/A Nov 26, 2024 @ 10:00 PM Supernus to Participate in the 36th Annual Piper S... Source: N/A Aug 12, 2024 @ 7:48 AM Attention-Deficit Hyperactivity Disorder Treatment... Source: Transparency Market Research Inc. Jul 23, 2024 @ 8:15 PM Supernus Pharmaceuticals to Announce Second Quarte... Source: N/A May 24, 2024 @ 3:53 PM Do Options Traders Know Something About Supernus (... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $.7 $.36 Diluted EPS $.69 $.36 Revenue $ $ 175.69M $ 168.33M Gross Profit $ $ 158.11M $ 150.41M Net Income / Loss $ $ 38.5M $ 19.92M Operating Income / Loss $ $ 40.85M $ 22.57M Cost of Revenue $ $ 17.58M $ 17.92M Net Cash Flow $ $ -20.42M $ -11.31M PE Ratio